Xiaohua Rong

792 total citations
24 papers, 621 citations indexed

About

Xiaohua Rong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaohua Rong has authored 24 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Xiaohua Rong's work include PI3K/AKT/mTOR signaling in cancer (10 papers), Protein Degradation and Inhibitors (4 papers) and Cancer-related Molecular Pathways (4 papers). Xiaohua Rong is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (10 papers), Protein Degradation and Inhibitors (4 papers) and Cancer-related Molecular Pathways (4 papers). Xiaohua Rong collaborates with scholars based in United States, Russia and Canada. Xiaohua Rong's co-authors include Cherie‐Ann O. Nathan, Fleurette Abreo, Gloria Caldito, Oleksandr Ekshyyan, Jonathan Glass, Tara Moore‐Medlin, Cheryl Clark, Tony Giordano, Mary Lowery Nordberg and Don A. Sibley and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Xiaohua Rong

24 papers receiving 614 citations

Peers

Xiaohua Rong

ONCOL

PRM

Chi‐Chen Fan Taiwan

Tara Moore‐Medlin United States

Raghvendra M. Srivastava United States

Garam Choi South Korea

Saroj K. Basak United States

Kanchan Vishnoi India

Minyue Zhang China

Ruting Xie China

Nupur Mukherjee India

Bihua Lin China

Chi‐Chen Fan Taiwan

Xiaohua Rong

423 ×1.2

158 ×0.8

ONCOL

77 ×0.7

PRM

40 ×0.5

161 ×1.9

Citations per year, relative to Xiaohua Rong Xiaohua Rong (= 1×) peers Chi‐Chen Fan

Countries citing papers authored by Xiaohua Rong

Since Specialization

Citations

This map shows the geographic impact of Xiaohua Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohua Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohua Rong more than expected).

Fields of papers citing papers by Xiaohua Rong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohua Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohua Rong. The network helps show where Xiaohua Rong may publish in the future.

Co-authorship network of co-authors of Xiaohua Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohua Rong. A scholar is included among the top collaborators of Xiaohua Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohua Rong. Xiaohua Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alam, Md Maksudul, et al.. (2023). Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC). Oncotarget. 14(1). 85–95. 14 indexed citations

Alam, Md Maksudul, et al.. (2022). Abstract 3209: Everolimus inhibits angiogenesis and lymphangiogenesis to affect tumor growth in TP53 mutant HNSCC. Cancer Research. 82(12_Supplement). 3209–3209. 1 indexed citations

Shishodia, Gauri, et al.. (2021). 4NQO enhances differential activation of DNA repair proteins in HPV positive and HPV negative HNSCC cells. Oral Oncology. 122. 105578–105578. 2 indexed citations

Alam, Md Maksudul, et al.. (2021). Rapalogs induce non‐apoptotic, autophagy‐dependent cell death in HPV‐negative TP53 mutant head and neck squamous cell carcinoma. Molecular Carcinogenesis. 61(1). 33–44. 7 indexed citations

Khandelwal, Alok R., Xiaohua Rong, Tara Moore‐Medlin, et al.. (2016). Photopreventive Effect and Mechanism of AZD4547 and Curcumin C3 Complex on UVB-Induced Epidermal Hyperplasia. Cancer Prevention Research. 9(4). 296–304. 13 indexed citations

Ekshyyan, Oleksandr, Alok R. Khandelwal, Xiaohua Rong, et al.. (2016). Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells.. PubMed. 8(11). 4822–4830. 18 indexed citations

Anandharaj, Arunkumar, Oleksandr Ekshyyan, Yi Jia, et al.. (2015). EBV and not HPV sensitizes tobacco-associated head and neck cancer cell line FaDu to radiotherapy. Acta Oto-Laryngologica. 136(4). 354–362. 2 indexed citations

Latimer, Brian, Oleksandr Ekshyyan, Tara Moore‐Medlin, et al.. (2015). Enhanced Systemic Bioavailability of Curcumin Through Transmucosal Administration of a Novel Microgranular Formulation.. PubMed. 35(12). 6411–8. 20 indexed citations

Jiang, Ru, Oleksandr Ekshyyan, Tara Moore‐Medlin, et al.. (2014). Association between human papilloma virus/Epstein–Barr virus coinfection and oral carcinogenesis. Journal of Oral Pathology and Medicine. 44(1). 28–36. 73 indexed citations

10.

Anandharaj, Arunkumar, Oleksandr Ekshyyan, Xiaohua Rong, et al.. (2014). Abstract 3192A: Senescence may play an important role in explaining the mechanisms of increased radiosensitivity of HPV- and EBV-associated HNSCC. Cancer Research. 74(19_Supplement). 3192A–3192A. 1 indexed citations

11.

Ekshyyan, Oleksandr, et al.. (2011). Efficacy and comparative effectiveness of sirolimus as an anticancer drug. The Laryngoscope. 121(5). 978–982. 12 indexed citations

12.

Clark, Cheryl, Tara Moore‐Medlin, Xiaohua Rong, et al.. (2011). Curcumin Inhibits Skin Squamous Cell Carcinoma Tumor Growth In Vivo. Otolaryngology. 145(1). 58–63. 40 indexed citations

13.

Ekshyyan, Oleksandr, et al.. (2011). Efficacy and Comparative Effectiveness of Sirolimus (Rapamune) as an Anticancer Drug. The Laryngoscope. 121(S4). 1 indexed citations

14.

Ekshyyan, Oleksandr, Glenn Mills, Timothy Lian, et al.. (2010). Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced‐stage head and neck squamous cell carcinoma. Head & Neck. 32(12). 1619–1628. 25 indexed citations

15.

Clark, Cheryl, Oleksandr Ekshyyan, Fleurette Abreo, et al.. (2010). Teasing out the best molecular marker in the AKT/mTOR pathway in head and neck squamous cell cancer patients. The Laryngoscope. 120(6). 1159–1165. 46 indexed citations

16.

Clark, Cheryl, et al.. (2010). Curcumin Inhibits Carcinogen and Nicotine-Induced Mammalian Target of Rapamycin Pathway Activation in Head and Neck Squamous Cell Carcinoma. Cancer Prevention Research. 3(12). 1586–1595. 63 indexed citations

17.

Ekshyyan, Oleksandr, Xiaohua Rong, Kavita M. Pattani, et al.. (2009). Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma. Molecular Cancer Therapeutics. 8(8). 2255–2265. 57 indexed citations

18.

Nathan, Cherie‐Ann O., Xiaohua Rong, Tony Giordano, et al.. (2007). Mammalian Target of Rapamycin Inhibitors as Possible Adjuvant Therapy for Microscopic Residual Disease in Head and Neck Squamous Cell Cancer. Cancer Research. 67(5). 2160–2168. 81 indexed citations

19.

Nathan, Cherie‐Ann O., Fleurette Abreo, Xiaohua Rong, et al.. (2004). Overexpressed eIF4E Is Functionally Active in Surgical Margins of Head and Neck Cancer Patients via Activation of the Akt/Mammalian Target of Rapamycin Pathway. Clinical Cancer Research. 10(17). 5820–5827. 77 indexed citations

20.

Harrison, Lynn, Melanie Smith, Xiaohua Rong, et al.. (2003). NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2. International Journal of Radiation Oncology*Biology*Physics. 57(5). 1405–1412. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact